CoChat
Sign Up
Cited by 15

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Riesgo cardiovascular en sujetos con alta probabilidad de síndrome metabólico y resistencia a la insulina. Estudio DESIRE

Goday, A., Gabriel, R., Ascaso, J.F., Franch, J., Ortega, R., Martínez, O., Lerones, N.·2008·Revista Clínica Española
DOI 10.1157/13126339
Open this paper in CoChat — free account

Abstract

Introduction and objectives The metabolic syndrome is an association of closely related alterations. The main objective of this study is to know the frequency of the metabolic syndrome and insulin resistance, and their role as cardiovascular risk indicators in an adult population assigned to Primary Care centers in Spain. Methods Subjects > or = 45 years with basal glycemia > or = 90 mg/dl and abdominal circumference > or = 94 cm (men) or > or = 80 cm (women). ATP III modified-criteria were used for the metabolic syndrome and HOMA index > 3.29 was used for insulin resistance. Cardiovascular risk was estimated by the Framingham and SCORE models. Results A total of 2,341 subjects (62 +/- 10 years; 44.6% males) were included. Frequency of metabolic syndrome and insulin resistance was 54.6% (52.5; 56.8) and 56.6% (54.5; 58.7) respectively. Metabolic syndrome was associated to a higher cardiovascular risk score with both Framingham (16 [15; 16] vs 11 [11; 12] p Conclusions Metabolic syndrome and insulin resistance are cardiovascular risk predictors. Early identification of metabolic syndrome by the use of simple clinical measures (basal glycemia and waist circumference) would make the intervention on the different disorders of metabolic syndrome possible.

Overview

Integrity signals

Registry

Crossref · 10.1157/13126339

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 5 references

Research works printed but not linked: 26

  1. Grundy, 2005, Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung and Blood Institute scientific statement, Circulation, 112, 1
  2. Reaven, 1988, Role of insulin resistance in human disease, Diabetes, 37, 1595, 10.2337/diab.37.12.1595 · DOI · Paper page
  3. Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404 · DOI · Paper page
  4. Alberti, 2006, Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabet Med, 5, 469, 10.1111/j.1464-5491.2006.01858.x · DOI · Paper page
  5. Lakka, 2002, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men, JAMA, 288, 2709, 10.1001/jama.288.21.2709 · DOI · Paper page
  6. Sattar, 2003, Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study, Circulation, 108, 414, 10.1161/01.CIR.0000080897.52664.94 · DOI · Paper page
  7. Pyörälä, 2000, Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinky Policemen Study, Arterioscler Thromb Vasc Biol, 20, 538, 10.1161/01.ATV.20.2.538 · DOI
  8. Sundstrom, 2006, Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: prospective, population based cohort study, BMJ, 332, 878, 10.1136/bmj.38766.624097.1F · DOI
  9. Levantesi, 2005, Metabolic syndrome and risk of cardiovascular events after myocardial infarction, J Am Coll Cardiol, 46, 277, 10.1016/j.jacc.2005.03.062 · DOI
  10. Lorenzo, 2003, The metabolic syndrome a predictor of type 2 diabetes. The San Antonio Heart Study, Diabetes Care, 26, 3153, 10.2337/diacare.26.11.3153 · DOI
  11. Bonora, 2003, The metabolic syndrome is an independent predictor of cardiovascular disease in type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications study, Diabet Med, 21, 52, 10.1046/j.1464-5491.2003.01068.x · DOI
  12. Gimeno Orna, 2004, Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2, Rev Esp Cardiol, 57, 507, 10.1016/S0300-8932(04)77141-9 · DOI
  13. Laakso, 2001, Insulin resistance and its impact on the approach to therapy of type 2 diabetes, Int J Clin Pract Suppl, 121, 8
  14. Bartnik, 2004, The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe: The Euro Heart Survey on diabetes and the heart, Eur Heart J, 25, 1880, 10.1016/j.ehj.2004.07.027 · DOI · Paper page
  15. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure, 1997, Arch Intern Med, 157, 2413, 10.1001/archinte.1997.00440420033005 · DOI · Paper page
  16. Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837 · DOI · Paper page
  17. Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 11, 987, 10.1016/S0195-668X(03)00114-3 · DOI · Paper page
  18. International guidelines for ethical review of epidemiological studies. Geneva: Council of International Organizations of Medical Sciences; 1991.
  19. García-Puig, 2006, Glucose metabolism alterations in patients with essential hypertension, Am J Med, 119, 318, 10.1016/j.amjmed.2005.09.010 · DOI
  20. Rexrode, 1998, Abdominal adiposity and coronary heart disease in women, JAMA, 280, 1843, 10.1001/jama.280.21.1843 · DOI
  21. Jeppesen, 2007, Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study, J Am Coll Cardiol, 49, 2112, 10.1016/j.jacc.2007.01.088 · DOI
  22. Gerstein, 2006, Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, Lancet, 368, 1096, 10.1016/S0140-6736(06)69420-8 · DOI · Paper page
  23. Sowers, 2003, Recommendations for special populations: diabetes mellitus and the metabolic syndrome, Am J Hypertens, 16, 41S, 10.1016/j.amjhyper.2003.07.009 · DOI
  24. Martínez-Larrad, 2005, Estudio de base poblacional en áreas rural y urbana de la provincia de Segovia, Med Clin (Barc), 125, 481, 10.1157/13080210 · DOI
  25. Athyros, 2005, MetS-Greece Collaborative Group. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study, Diabetes Obes Metab, 7, 397, 10.1111/j.1463-1326.2004.00409.x · DOI
  26. Qiao, 2006, Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women, Diabetologia, 49, 2837, 10.1007/s00125-006-0438-6 · DOI

Cited by

Sorted by citations

Metadata

Authors
Goday, A., Gabriel, R., Ascaso, J. F., Franch, J., Ortega, R., Martínez, O., & Lerones, N.
Venue
Revista Clínica Española
Publisher
Elsevier BV
Published
2008-09
Volume
208
Issue
8
Pages
377-385
ISSN
0014-2565
DOI
10.1157/13126339
Cited by
15
References
5
Language
es
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review